Antibody

1,018개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,018 programs
AntibodyLimited DatastaleShen FengPhase 2

Cadonilimab+Gem/Cis (Cadonilimab+Gem/Cis)

Intrahepatic Cholangiocarcinoma · Intrahepatic Cholangiocarcinoma

#IntrahepaticCholangiocarcinoma#Antibody#Phase2#monoclonal-antibody#Shen
Trials 1Status Active
AntibodyLimited DatastaleShanghai General Hospital, Shan…Phase 2

Cadonilimab+S-1or Capecitabine (Cadonilimab+S-1or Capecitabine)

Pancreatic Neoplasms · Pancreatic Neoplasms

#PancreaticNeoplasms#Antibody#Phase2#monoclonal-antibody#Shanghai
Trials 1Status Recruiting
AntibodyLimited DatastaleSun Yat-Sen Memorial Hospital o…Preclinical

Camerlizumab (Camerlizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#monoclonal-antibody#Sun
Trials 1Status Active
AntibodyLimited DatastaleJiangsu HengruiPhase 2

Camrelizumab and Bevacizumab (Camrelizumab and Bevacizumab)

Recurrent Glioblastoma · Recurrent Glioblastoma

#RecurrentGlioblastoma#Antibody#Phase2#monoclonal-antibody#Jiangsu
Trials 1Status Discontinued
AntibodyLimited DatastaleJiangsu HengruiPhase 3

Camrelizumab and Cetuximab (Camrelizumab and Cetuximab)

Head and Neck Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase3#monoclonal-antibody#Jiangsu
Trials 1Status Recruiting
AntibodyLimited DatastaleJiangsu HengruiPhase 3

Camrelizumab and Chemotherapy (Camrelizumab and Chemotherapy)

Head and Neck Squamous Cell Carcinoma · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#Antibody#Phase3#monoclonal-antibody#Jiangsu
Trials 1Status Recruiting
AntibodyLimited DatastaleJiangsu HengruiPhase 2

Camrelizumab+cetuximab+chemotherapy (Camrelizumab+cetuximab+chemotherapy)

Squamous Cell Carcinoma of Head and Neck · Squamous Cell Carcinoma of Head and Neck

#SquamousCellCarcinomaofHeadandNe#Antibody#Phase2#monoclonal-antibody#Jiangsu
Trials 1Status Active
AntibodyLimited DatastaleNovartis PharmaceuticalsPhase 3

AIN457 (Canakinumab, Canakinumab (AIN457))

Periodic Fevers Syndrome · Periodic Fevers Syndrome

#PeriodicFeversSyndrome#Antibody#Phase3#monoclonal-antibody#Novartis
Trials 1Status Active
AntibodyLimited DatastaleKing Faisal Specialist Hospital…Preclinical

Capecitabine (Xelodaâ, Capecitabine, Capecitabine (Xelodaâ), XRT & Cetuximab (Erbitux®))

Colon Rectal Cancer Duke Stage Stageval · Colon Rectal Cancer Duke Stage Stageval

#ColonRectalCancerDukeStageStagev#Antibody#Preclinical#monoclonal-antibody#King
Trials 1Status Active
AntibodyLimited DatastaleSouth Eastern European Research…Phase 2

Capecitabine and Bevacizumab (Capecitabine and Bevacizumab)

Breast Cancer; Metastasis · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#Metastasis+1
Trials 1Status Active
AntibodyLimited DatastaleUniversity of Medicine and Dent…Phase 2

Capecitabine and Cetuximab (Capecitabine and Cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#University
Trials 1Status Discontinued
AntibodyLimited DatastaleRochePhase 3

Capecitabine plus bevacizumab (Capecitabine plus bevacizumab)

Elderly Patients; Metastatic Colorectal Cancer · Elderly Patients

#ElderlyPatients#Antibody#Phase3#monoclonal-antibody#MetastaticColorectalCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleShandong Cancer Hospital and In…Phase 2

trastuzumab (Herceptin, Capecitabine,Trastuzumab, and Pertuzumab)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#monoclonal-antibody#Shandong
Trials 1Status Active
AntibodyLimited DatastaleSanofiPhase 3

Caplacizumab (Caplacizumab)

Acquired Thrombotic Thrombocytopenic Purpura · Acquired Thrombotic Thrombocytopenic Pur

#AcquiredThromboticThrombocytopen#Antibody#Phase3#monoclonal-antibody#Sanofi
Trials 1Status Active
AntibodyLimited DatastaleThe Netherlands Cancer InstitutePhase 2

atezolizumab (Tecentriq, Carbo/cyclo + atezolizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#The
Trials 1Status Recruiting
AntibodyLimited DatastaleXiangya Hospital of Central Sou…Phase 1

Cardunilizumab (Cardunilizumab)

Sarcoma, Soft Tissue · Sarcoma, Soft Tissue

#SarcomaSoftTissue#Antibody#Phase1#monoclonal-antibody#Sarcoma+2
Trials 1Status Active
AntibodyLimited DatastaleFudan UniversityPhase 2

Carrelizumab (Carrelizumab)

Breast Neoplasm; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasm+2
Trials 1Status Recruiting
AntibodyLimited DatastaleNeovii BiotechPhase 3

Removab (Catumaxomab, Catumaxomab (Removab))

EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast); Malignant Ascites · EpCam Positive Tumor (e.g.Ovarian, Gastr

#EpCamPositiveTumoregOvarianGastr#Antibody#Phase3#monoclonal-antibody#EpCamPositiveTumoregOvarian+3
Trials 1Status Active
AntibodyLimited DatastaleUniversity of Illinois at Chica…Approved

CDP870, tradename Cimzia (Certolizumab pegol, Certolizumab pegol (CDP870, tradename Cimzia))

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#monoclonal-antibody#University
Trials 1Status Active
AntibodyLimited DatastaleRochePreclinical

Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors (Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors)

Colorectal Cancer Metastatic · PD-1

#PD-1#Antibody#Preclinical#monoclonal-antibody#ColorectalCancerMetastatic+1
Trials 1Status Recruiting

22 / 51 pages

← PreviousNext →